Pfizer AG - Adriblastin RD 150 mg, Injektionspräparat |
| 50357 | | 04 | | Adriblastin RD 150 mg | | Injektionspräparat | | L01DB01 | | Doxorubicin | | 27.10.1989 | | |
|
Composition |
Praeparatio cryodesiccata: doxorubicini hydrochloridum 150 mg, lactosum monohydricum, E 218 15 mg pro vitro. |
Packungsbestandteile |
| Injection preparation | | |
|
Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
No entries have been found. |
|